DE69327536T2 - Fibrinogenrezeptor-antagonisten - Google Patents
Fibrinogenrezeptor-antagonistenInfo
- Publication number
- DE69327536T2 DE69327536T2 DE69327536T DE69327536T DE69327536T2 DE 69327536 T2 DE69327536 T2 DE 69327536T2 DE 69327536 T DE69327536 T DE 69327536T DE 69327536 T DE69327536 T DE 69327536T DE 69327536 T2 DE69327536 T2 DE 69327536T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- receptor antagonists
- fibrinogen receptor
- date
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002319 fibrinogen receptor antagonist Substances 0.000 title 1
- 210000001772 blood platelet Anatomy 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96066892A | 1992-10-14 | 1992-10-14 | |
PCT/US1993/009730 WO1994008962A1 (en) | 1992-10-14 | 1993-10-12 | Fibrinogen receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69327536D1 DE69327536D1 (de) | 2000-02-10 |
DE69327536T2 true DE69327536T2 (de) | 2000-07-06 |
Family
ID=25503460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69327536T Expired - Fee Related DE69327536T2 (de) | 1992-10-14 | 1993-10-12 | Fibrinogenrezeptor-antagonisten |
Country Status (8)
Country | Link |
---|---|
US (2) | US5559127A (de) |
EP (1) | EP0664792B1 (de) |
JP (1) | JPH08502484A (de) |
AT (1) | ATE188379T1 (de) |
AU (1) | AU675680B2 (de) |
CA (1) | CA2144763A1 (de) |
DE (1) | DE69327536T2 (de) |
WO (1) | WO1994008962A1 (de) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012181A1 (en) * | 1992-12-01 | 1994-06-09 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
GB9225141D0 (en) * | 1992-12-01 | 1993-01-20 | Smithkline Beecham Corp | Chemical compounds |
KR950701329A (ko) * | 1993-02-19 | 1995-03-23 | 유미꾸라 레이이찌 | 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof) |
US6169107B1 (en) * | 1993-04-28 | 2001-01-02 | Sumitomo Pharmaceutical Co., Ltd. | Indoloylguanidine derivatives |
US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
EP0760658B1 (de) * | 1994-05-27 | 2002-11-13 | Merck & Co. Inc. | Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption |
CA2168858A1 (en) * | 1994-06-06 | 1995-12-14 | Shinichiro Ono | Novel fused-ring carboxylic acid compound or salt thereof, and medicinal use thereof |
US5451578A (en) * | 1994-08-12 | 1995-09-19 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5525617A (en) * | 1994-08-24 | 1996-06-11 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5494921A (en) * | 1994-09-16 | 1996-02-27 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
DE19532311A1 (de) * | 1995-09-01 | 1997-03-06 | Basf Ag | Benzoylderivate |
EP0854869B1 (de) | 1995-09-29 | 2004-08-25 | Eli Lilly And Company | Spiro verbindungen als inhibitoren der fibrinogen-abhängigen blutplättchen aggregation |
US5789421A (en) * | 1995-10-26 | 1998-08-04 | Merck & Co., Inc. | Fibrinogen receptor antagonist |
AU702025B2 (en) * | 1995-10-26 | 1999-02-11 | Merck & Co., Inc. | Fibrinogen receptor antagonist |
US5760028A (en) * | 1995-12-22 | 1998-06-02 | The Dupont Merck Pharmaceutical Company | Integrin receptor antagonists |
US5780480A (en) * | 1996-02-28 | 1998-07-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
TR199802386T2 (xx) * | 1996-05-20 | 1999-02-22 | Darwin Discovery Limited | Benzofuran karboksamidler ve bunlar�n terap�tik kullan�m�. |
JP2001504479A (ja) | 1996-11-15 | 2001-04-03 | ダーウィン・ディスカバリー・リミテッド | 二環式アリールカルボキシアミド及びその治療的使用 |
CA2279927A1 (en) * | 1997-02-06 | 1998-08-13 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
ZA988735B (en) * | 1997-10-06 | 2000-03-23 | Du Pont Pharm Co | An efficient method for the conversion of nitriles to amidines. |
JP2002515891A (ja) * | 1997-12-19 | 2002-05-28 | スミスクライン・ビーチャム・コーポレイション | 新規なピペリジン含有化合物 |
EP1054871A2 (de) | 1998-04-01 | 2000-11-29 | Du Pont Pharmaceuticals Company | Pyrimidine und triazine als integrinantagonisten |
TW555759B (en) | 1998-06-08 | 2003-10-01 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
TWI248435B (en) * | 1998-07-04 | 2006-02-01 | Boehringer Ingelheim Pharma | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
CN1308534A (zh) * | 1998-07-06 | 2001-08-15 | 斯克里普斯研究学院 | 血管生成抑制剂 |
US6248770B1 (en) | 1998-07-09 | 2001-06-19 | Boehringer Ingelheim Pharma Kg | Benzimidazoles having antithrombotic activity |
FR2786184B1 (fr) * | 1998-11-24 | 2002-09-20 | Hoechst Marion Roussel Inc | Nouveaux derives du benzofurane, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
FR2799756B1 (fr) * | 1999-10-15 | 2001-12-14 | Adir | Nouveaux derives benzothiopheniques, benzofuraniques et indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
DE19951360A1 (de) * | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
CO5261573A1 (es) | 1999-11-19 | 2003-03-31 | Novartis Ag | Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion |
US6451832B2 (en) | 1999-12-23 | 2002-09-17 | Boehringer Ingelheim Pharma Kg | Benzimidazoles with antithrombotic activity |
KR20040063144A (ko) | 2001-11-09 | 2004-07-12 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 단백질 키나제 억제제로서 유용한 벤즈이미다졸 |
WO2003105846A1 (en) * | 2002-06-13 | 2003-12-24 | Vertex Pharmaceuticals Incorporated | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
WO2004014905A1 (en) * | 2002-08-08 | 2004-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted benzimidazole compounds |
DE10237722A1 (de) | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
US20060127385A1 (en) | 2002-12-06 | 2006-06-15 | The Trustees Of Boston University | Method for sustaining enos activity |
US7094790B2 (en) | 2003-05-07 | 2006-08-22 | Abbott Laboratories | Fused bicyclic-substituted amines as histamine-3 receptor ligands |
MXPA06000538A (es) * | 2003-07-15 | 2006-03-30 | Smithkline Beecham Corp | Compuestos novedosos. |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US20050209284A1 (en) * | 2004-02-12 | 2005-09-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Tec kinase inhibitors |
US7772271B2 (en) * | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
WO2006019831A1 (en) * | 2004-07-14 | 2006-02-23 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
US7868037B2 (en) * | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
JP2008507518A (ja) * | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス,インコーポレーテッド | C型肝炎を治療するためのチエノピリジン |
US20100130737A1 (en) * | 2005-02-18 | 2010-05-27 | Takeda Pharmaceutical Company Limited | Regulating Agent of GPR34 Receptor Function |
PE20061319A1 (es) * | 2005-04-22 | 2006-12-28 | Wyeth Corp | Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina |
AU2006264649A1 (en) | 2005-06-30 | 2007-01-11 | Prosidion Limited | GPCR agonists |
DE102006021878A1 (de) * | 2006-05-11 | 2007-11-15 | Sanofi-Aventis | Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
GB0812648D0 (en) * | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
MX2011003239A (es) | 2008-09-26 | 2011-04-28 | Merck Sharp & Dohme | Nuevos derivados de bencimidazol ciclicos utiles como agentes anti-diabeticos. |
WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
EP2352374B1 (de) | 2008-10-29 | 2014-09-24 | Merck Sharp & Dohme Corp. | Neue cyclische benzimidazolderivate als antidiabetika |
CA2741672A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
EP2473488A4 (de) * | 2009-09-04 | 2013-07-17 | Zalicus Pharmaceuticals Ltd | Substituierte heterocyclische derivate zur schmerz- und epilepsiebehandlung |
US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
CR20170420A (es) | 2015-03-13 | 2017-10-03 | Forma Therapeutics Inc | Compuestos y composiciones de alfa-cinamida como inhibidores de hdac8 |
TN2020000159A1 (en) | 2016-10-04 | 2022-04-04 | Merck Sharp & Dohme | BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS |
JP2020530838A (ja) | 2017-08-04 | 2020-10-29 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | がん治療のためのベンゾ[b]チオフェンSTINGアゴニスト |
AU2018311965A1 (en) | 2017-08-04 | 2020-02-13 | Merck Sharp & Dohme Llc | Combinations of PD-1 antagonists and benzo[b]thiophene sting antagonists for cancer treatment |
CN111971277B (zh) | 2018-04-03 | 2023-06-06 | 默沙东有限责任公司 | 作为sting激动剂的苯并噻吩及相关化合物 |
WO2019195063A1 (en) | 2018-04-03 | 2019-10-10 | Merck Sharp & Dohme Corp. | Aza-benzothiophene compounds as sting agonists |
IL293592A (en) | 2019-12-06 | 2022-08-01 | Vertex Pharma | Transduced tetrahydrofurans as sodium channel modulators |
EP4347031A1 (de) | 2021-06-04 | 2024-04-10 | Vertex Pharmaceuticals Incorporated | N-(hydroxyalkyl(hetero)aryl)tetrahydrofurancarboxamide als modulatoren von natriumkanälen |
CA3220039A1 (en) | 2021-06-14 | 2022-12-22 | Jr. David St. Jean | Urea derivatives which can be used to treat cancer |
CA3226162A1 (en) | 2021-07-09 | 2023-01-12 | Plexium, Inc. | Aryl compounds and pharmaceutical compositions that modulate ikzf2 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2549999A1 (de) * | 1975-11-07 | 1977-05-12 | Boehringer Mannheim Gmbh | Piperidin-derivate und verfahren zu ihrer herstellung |
FR2334358A1 (fr) * | 1975-12-12 | 1977-07-08 | Sogeras | Nouveaux medicaments derives de l'indole |
US4064125A (en) * | 1976-10-29 | 1977-12-20 | E. R. Squibb And Sons, Inc. | Substituted amides having antiinflammatory activity |
DE3065026D1 (en) * | 1979-05-23 | 1983-11-03 | Beecham Wuelfing Gmbh & Co Kg | Phenylsulphonamide derivatives, a process for their preparation and their use as medicines |
KR880007441A (ko) * | 1986-12-11 | 1988-08-27 | 알렌 제이.스피겔 | 스피로-치환된 글루타르아미드 이뇨제 |
US4879313A (en) * | 1988-07-20 | 1989-11-07 | Mosanto Company | Novel platelet-aggregation inhibitors |
US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
NZ234264A (en) * | 1989-06-29 | 1993-05-26 | Warner Lambert Co | N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions |
US5064814A (en) * | 1990-04-05 | 1991-11-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
IL99539A0 (en) * | 1990-09-27 | 1992-08-18 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical compositions containing them |
IL99538A0 (en) * | 1990-09-27 | 1992-08-18 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical compositions containing them |
IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
US5217994A (en) * | 1991-08-09 | 1993-06-08 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
US5416099A (en) * | 1991-10-29 | 1995-05-16 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5227490A (en) * | 1992-02-21 | 1993-07-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
-
1993
- 1993-10-12 EP EP93923845A patent/EP0664792B1/de not_active Expired - Lifetime
- 1993-10-12 CA CA002144763A patent/CA2144763A1/en not_active Abandoned
- 1993-10-12 AU AU53574/94A patent/AU675680B2/en not_active Ceased
- 1993-10-12 WO PCT/US1993/009730 patent/WO1994008962A1/en active IP Right Grant
- 1993-10-12 JP JP6510209A patent/JPH08502484A/ja active Pending
- 1993-10-12 AT AT93923845T patent/ATE188379T1/de active
- 1993-10-12 DE DE69327536T patent/DE69327536T2/de not_active Expired - Fee Related
- 1993-10-12 US US08/416,770 patent/US5559127A/en not_active Expired - Fee Related
-
1996
- 1996-09-23 US US08/717,952 patent/US5721253A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU675680B2 (en) | 1997-02-13 |
DE69327536D1 (de) | 2000-02-10 |
JPH08502484A (ja) | 1996-03-19 |
US5721253A (en) | 1998-02-24 |
CA2144763A1 (en) | 1994-04-28 |
WO1994008962A1 (en) | 1994-04-28 |
EP0664792B1 (de) | 2000-01-05 |
AU5357494A (en) | 1994-05-09 |
EP0664792A1 (de) | 1995-08-02 |
EP0664792A4 (de) | 1996-09-25 |
ATE188379T1 (de) | 2000-01-15 |
US5559127A (en) | 1996-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69327536D1 (de) | Fibrinogenrezeptor-antagonisten | |
ATE167476T1 (de) | Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel. | |
BR9611175A (pt) | Compostos ou suas composições e uso dos mesmo | |
AU1889392A (en) | Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | |
ES2154270T3 (es) | Nuevos derivados del imidazol, su preparacion y sus aplicaciones terapeuticas. | |
ZA948670B (en) | New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions | |
SG55184A1 (en) | New imidazopyridines | |
NO962664D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
FR2681784B1 (fr) | Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides. | |
GR3030626T3 (en) | 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
ATE169019T1 (de) | Xanthinderivate als adenosin-a1 rezeptor antagonisten | |
ATE188692T1 (de) | Fibrinogenrezeptorantagonisten | |
AU7345391A (en) | Derivative of beta-phenylisoserine, preparation and utilisation thereof | |
ZA9429B (en) | Pyrrolidine derivatives their preparation and medicaments containing them | |
DK0668852T3 (da) | Substituerede orthoethenylphenyleddikesyrederivater | |
TW261605B (de) | ||
SE9401596D0 (sv) | New compounds | |
NO305519B1 (no) | Benzo[f]kinoksalindionderivater og legemidler inneholdende disse | |
NO962251L (no) | Substituerte aminoalkyaminopyridiner | |
KR960700053A (ko) | 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |